On the outcome of the interactive, multi-stakeholder round table of the ministerial segment: Taking stock of the implementation of all commitments made to jointly address and counter the world drug problem, in particular in the light of the 2019 target date for the goals set in paragraph 36 of the Political Declaration; analysing existing and emerging trends, gaps and challenges:
Norway: The most salient points in the roundtable were as follows. Many have welcomed the tangible progress made towards the targets set in 2009 including enhanced sharing of information, data collection and national efforts made towards such. Many countries have implemented scientific evidence-based approaches centering around public health. Speakers noted that the challenge they face have diversified. The illicit cultivation and production of illicit crops such as opium is at a record high as are the precursors and numbers of deaths relating to the use of drugs. Many countries failed to provide adequate and accessible treatment to those in need. Countries most effected often didn’t have the means to address the problem. Poly-drug use and abuse of prescription drugs as well as violence and increased homicide rates were mentioned as emerging worries. Women were underrepresented in access to treatment and stigma and violent law enforcement responses, including extrajudicial killings, persisted as a problem. Accessibility of pain relief remain low to nonexistent in many part of the world. In the view of the participants, a particular challenge is posed by NPS, including fentanyl and its analogues for which there is a lack of national response. Countries should strengthen their capacities to detect NPS, to target online sales and to reduce global demand to these substances. Speakers also noted illicit financial flows related to drug trafficking and there Is a lack of information to understand these mechanisms. An international collaboration is needed to properly address this phenomena. It was noted by several speakers that the adherence to the drug control convention is essential to the international drug control system and concerns about the effects of the legalization of cannabis on to the wellbeing of young people was mentioned. The international community needs to step up its efforts to address remaining gaps, share more information and deploy more resources. In the view of participants, the next decade should focus on joint commitments with the focus on the operational recommendations of the UNGASS outcome document. Speakers also recognized that the goals set out in 2009 to remain relevant and that both documents should be implemented in a balanced and comprehensive matter. Issues about the ARQ have also emerged, support was expressed to the UNODC to update it.
On the outcome of the interactive, multi-stakeholder round table of the ministerial segment: Safeguarding the future: enhancing our efforts to respond to the world drug problem through strengthening international cooperation, including means of implementation, capacity-building and technical assistance, on the basis of common and shared responsibility:
Mexico: I will present the salient points of the roundtable. Many statements included references to:
- The review of commitments made, highlights of importance of common and shared responsibility
- One size doesn’t fit all
- Integration of balanced, multidisciplinary, comprehensive and human rights based approaches.
- Underscore the mutual reinforcing of the 2009, 2014 and 2016 documents
- Speakers recall responsibility to control and implement effective strategies under the conventions and by the commitments over the last decades
- 3 conventions and other international instruments are the cornerstones
- Designing and implementing drug policies according to their own needs, by applicable international law
- A number of statements call for decriminalization, while other express concern for efforts regarding regulation of substances
- Proportionate sentencing and alternatives to conviction
- Implementing join commitments made in last decade.
- Ensure availability and accessibility of controlled substances while preventing their diversion and trafficking
- Non discriminatory access to healthcare and treatment programs.
- Minimising adverse public health consequences for drug abuse
- Highlighting specific needs of vulnerable populations – including women, youth and children
- Preventing HIV, HCV and other diseases associated with drug abuse
- Expanding drag markets and increasing risks posed by them
- New synthetic opioids pose huge risk
- Need to see increasing links with organized crime, illicit drug related activities
- Strengthening cross border collaboration to eliminate precursors
- Need capacity building to ensure all member states, in particular those most affected, can counter the world drug problem
- Enhance cooperation at national regional and international levels
- All stakeholders – civil society, scientific community and academia are important to include
- Encouragement of UNODC to further cooperate with other UN bodies
- Stigmatization and social disintegration needs to be reduced
- Drug policies should be in line with SDGs
- High quality and reliable data and sharing of data is important
- Reiterated calls for streamlining and strengthening data analysis tools, including the ARQ